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L system, is a major contributor to NLRP3
inflammasome activation during viral
infections.
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The NLRP3 inflammasome assembles in response to
danger signals, triggering self-cleavage of procas-
pase-1 and production of the proinflammatory cyto-
kine IL-1b. Although virus infection activates the
NLRP3 inflammasome, the underlying events remain
incompletely understood. We report that virus acti-
vation of the NLRP3 inflammasome involves the
20,50-oligoadenylate (2-5A) synthetase(OAS)/RNase
L system, a component of the interferon-induced
antiviral response that senses double-stranded
RNA and activates endoribonuclease RNase L to
cleave viral and cellular RNAs. The absence of RNase
L reduces IL-1b production in influenza A virus-in-
fected mice. RNA cleavage products generated by
RNase L enhance IL-1b production but require the
presence of 20,30-cyclic phosphorylated termini char-
acteristic of RNase L activity. Additionally, these
cleavage products stimulate NLRP3 complex forma-
tion with the DExD/H-box helicase, DHX33, andmito-
chondrial adaptor protein, MAVS, which are each
required for effective NLRP3 inflammasome activa-
tion. Thus, RNA cleavage events catalyzed by RNase
L are required for optimal inflammasome activation
during viral infections.
INTRODUCTION
The innate immune system provides a rapid protective response
against a wide range of cellular insults sensed by the host as
danger signals, including those associated with viral infections.
Nucleic acid motifs produced by viruses often function as a
type of danger signal known as pathogen-associated molecular
patterns (PAMPs) that are absent in uninfected cells (Schroder
and Tschopp, 2010). Viral nucleic acids that function as PAMPs
include double-stranded RNA (dsRNA), 50-triphosphorylated
(triP) single-strand RNA (ssRNA) containing segments rich in
polyuridine (Saito et al., 2008), and cytoplasmic genomic DNA466 Cell Host & Microbe 17, 466–477, April 8, 2015 ª2015 Elsevier In(Schroder and Tschopp, 2010). These nucleic acids are sensed
by germline-encoded pathogen recognition receptors (PRRs)
that initiate innate immune signaling (Takeuchi and Akira,
2010). The PRRs for viral nucleic acids include membrane-asso-
ciated Toll-like receptors (TLRs) for dsRNA (TLR3), ssRNA
(TLR7/8), and dsDNA (TLR9) (Takeuchi and Akira, 2010), cyto-
plasmic DNA sensors (cGAS, DAI/Zbp1, IFI16, and AIM2) (Unter-
holzner, 2013), and cytoplasmic sensors of dsRNA and/or 50-triP
ssRNA (RIG-I-like receptors [RLRs] RIG-I and MDA5, Takeuchi
and Akira, 2010; DExD/H-box helicases [DDX1, DDX21,
DHX33, and DHX36], Liu et al., 2014; Mitoma et al., 2013; Zhang
et al., 2011; protein kinase R [PKR], Yim and Williams, 2014; and
20,50-oligoadenylate synthetases [OAS], Chakrabarti et al., 2011).
The NOD-like receptor (NLR) family includes additional PRRs
that sense microbial PAMPs in the cytosol (Schroder and
Tschopp, 2010). Different NLR members (including NLRP1,
NLRP3, and NLRC4) or non-NLR proteins (notably AIM2) func-
tion in large molecular machines known as inflammasomes.
The NLRP3 inflammasome is implicated in the host response
to many different types of RNA viruses, including influenza A
virus (IAV) (Allen et al., 2009; Ichinohe et al., 2009; Kanneganti
et al., 2006a; Thomas et al., 2009), hepatitis C virus (Negash
et al., 2013), Sendai virus (Kanneganti et al., 2006a), encephalo-
myocarditis virus (Rajan et al., 2011), vesicular stomatitis virus
(VSV) (Rajan et al., 2011), West Nile virus (Ramos et al., 2012),
and HIV (Guo et al., 2014), and DNA viruses, including adeno-
virus (Muruve et al., 2008), varicella zoster (Nour et al., 2011),
and herpes virus (Nour et al., 2011). In addition, the NLRP3 in-
flammasome has been linked to inherited autoinflammatory
diseases, known as cryopyrin-associated periodic syndromes
(Lamkanfi and Dixit, 2014; Ozkurede and Franchi, 2012).
Activation of the NLRP3 inflammasome requires two types of
signals. The first signal (priming) occurs when microbial ligands
or endogenous cytokines induce transcription by NF-kB of the
NLRP3 and proIL-1b genes. Signal 2 (direct activation from
host damage) releases auto-inhibition of NLRP3, allowing inter-
action with ASC through pyrin domains (PYD) present in both
proteins. NLRP3 then nucleates prion-like filaments of ASC
providing a platform for the zymogen, procaspase-1 binding
through caspase activation and recruitment domains (CARD)
(Cai et al., 2014; Lu et al., 2014). Assembly of the inflammasome
results in self-cleavage of procaspase-1 (p45) into its activatedc.
form (a heterodimer of two cleavage products, p10 and p20).
Caspase-1 is a cysteine protease that cleaves proIL-1b and
proIL-18 at aspartic residues to generate the mature cytokines
that are secreted and function in host responses to infection. In-
flammasome activation leads to pyroptosis or inflammatory cell
death with pore formation and cell swelling, thereby eliminating
virus-infected cells (Bergsbaken et al., 2009). Despite consider-
able progress in understanding the biochemistry and biology of
inflammasomes, precisely how viruses induce activation of the
NLRP3 inflammasome remains largely unresolved. Here we
investigated a possible role for RNase L in regulation of the
NLRP3 inflammasome during viral infections.
RNase L is a ubiquitous endoribonuclease for ssRNA that is
often activated in virus-infected cells (Chakrabarti et al., 2011).
IFNs induce transcription of a family of oligoadenylate synthe-
tase (OAS) genes that encode proteins that produce 20,50-linked
oligonucleotides of the formula px5
0A(20p50A)n; x = 1–3; n R 2
(2-5A) from ATP when stimulated by viral dsRNA (Kerr and
Brown, 1978). 2-5A binds to monomeric, inactive RNase L,
causing dimers to form (Dong and Silverman, 1995) that, in the
presence of ADP or ATP, become catalytically active (Huang
et al., 2014). RNase L mediates its antiviral activity by cleaving
viral and cellular ssRNAs predominantly after UpAp and UpUp
dinucleotides (Wreschner et al., 1981). Activation of RNase L in-
duces autophagy (Chakrabarti et al., 2012) and apoptosis (Zhou
et al., 1997), both of which contribute to its antiviral effects. In
addition to the direct antiviral effects of RNase L from degrada-
tion of viral and cellular RNA, RNase L also initiates signaling
events that regulate type I IFN production. RNase L either posi-
tively or negatively regulates viral induction of type I IFNs de-
pending on basal levels of OAS and RNase L in different cell
types (Banerjee et al., 2014; Malathi et al., 2007). The RNA cleav-
age products generated by RNase L often have double-stranded
regions (because RNase L is a ssRNA-specific endoribonu-
clease), a 50-hydroxyl and a 20,30-cyclic phosphoryl group char-
acteristic of metal ion-independent ribonucleases (Cooper
et al., 2014). Signaling to the IFN-b gene by viral or cellular
RNA cleavage products from RNase L action requires RIG-I
and/or MDA5 and MAVS (Malathi et al., 2007). The role of RNase
L in regulating type I IFN production led us to examine the
possible effects of RNase L on inflammasome activation during
viral infections. Our findings indicate that RNase L enhances
NLRP3 inflammasome activation during viral infections in a
signaling pathway that includes both DHX33 and MAVS. Activa-
tion of the NLRP3 inflammasome in bone marrow-derived den-
dritic cells (BMDCs) and in human THP-1-derived macrophages
occurred in response to direct activation of RNase L with 2-5A or
transfection with cellular or viral RNA cleaved by RNase L. Our
findings suggest a role for RNase L in inflammatory signaling
that enhances survival from viral infections.
RESULTS
RNase L Enhances IL-1b Induction and Improves Animal
Survival during IAV Infections
To determine the possible effect of RNase L on IL-1b induction
during viral infections in vivo, wild-type (WT) and Rnasel/
mice were infected with the mouse-adapted influenza A virus
(IAV), strain A/PR/8/H1N1, by the intranasal (i.n.) route. AtCell15 days post-infection (dpi), 80% of the WT animals survived
infection compared with only 34% survival for the Rnasel/
mice (Figure 1A). In contrast, there were no significant
differences in body weights between the infected WT and
Rnasel/ mice (Figure 1B). Levels of IL-1b were measured
both in lung tissue extracts and in brochoaveolar lavage fluid
(BALF) at 2 dpi (Figures 1C and 1D). Deletion of RNase L
decreased mean levels of IL-1b obtained after IAV infections
by 90% and 75% of WT levels in lung tissue and BALF, respec-
tively. IAV-induced levels of TNF-a were moderately reduced by
deletion of RNase L in lung tissue and BALF, possibly due to sec-
ondary induction of TNF-a by IL-1b (Thomas et al., 2009) (Figures
1E and 1F). Previously, we reported decreased IFN-b production
in Rnasel/ mice after infection with the picornavirus, encepha-
lomyocarditis virus, or with the rhabdovirus, vesicular stomatitis
virus (VSV) (Malathi et al., 2007). Similarly, after IAV infection
there was significantly less IFN-b in BALF from Rnasel/ mice
compared with WT mice (Figure S1). At 7 dpi, viral yields were
modestly increased (by 4-fold) in the lungs of Rnasel/ mice
compared to WT mice (Figure 1G). These results show that, in
IAV-infected mice, RNase L has prosurvival and antiviral effects
that correlate with increased production of IL-1b and IFN-b.
RNase L Enhances Inflammasome Activation during
Viral Infections
Secretion of IL-1b following LPS priming and VSV or IAV infec-
tions was decreased by 80% in Rnasel/ BMDC (Figure 2A).
LPS treatment alone primed inflammasomes but only minimally
induced IL-1b. In addition, in the absence of LPS, VSV or IAV
alone failed to induce IL-1b (Figure S2). The RNase L effect on
IL-1b induction was apparent between 8 and 18 hr post-infec-
tion with VSV and between 24 and 36 hr of infection with IAV
(Figure S2). Similarly, deletion of RNase L reduced IL-1b induc-
tion by 70% after priming with TNF-a followed by VSV infection
(Figure 2B). ATP activates the NLRP3 inflammasome through
the P2X7 ion channel, leading to potassium efflux (Franchi
et al., 2007). RNase L had no effect on IL-1b induction by LPS
and ATP, suggesting that RNase L is not a general regulator
of inflammasome activation (Figure 2C). To determine if RNase
L affects inflammasome priming (signal 1), levels of IL-1b
mRNA were measured by qRT-PCR. However, RNase L had
no effect on IL-1b mRNA induction in BMDC by LPS alone or
by LPS followed by VSV infection (Figure 2D). Also, there was
no effect of RNase L on TNF-a induction by LPS or by LPS/VSV
(Figure 2E). To assess the effect of RNase L on inflammasome
activation (signal 2), processing of procaspase-1 (45 kDa) to
one of its self-cleavage products (the 20 kDa subunit of mature
active caspase-1) and of proIL-1b (31 kDa) to mature IL-1b
(17 kDa) was monitored by immunoblotting (Figure 2F). LPS
treatment by itself failed to produce either activated caspase-1
p20 or mature IL-1b (p17). In contrast, LPS plus either VSV or
IAV infection of WT BMDC caused a large increase in levels of
mature IL-1b (p17) and a clearly detectable increase in cas-
pase-1 p20. However, in Rnasel/ BMDC, LPS treatment fol-
lowed by VSV or IAV infection produced only minimal amounts
of IL-1b p17 or caspase-1 p20 (Figure 2F). These findings are
consistent with a role for RNase L in inflammasome activation
(signal 2), but not in priming (signal 1), during these viral
infections.Host & Microbe 17, 466–477, April 8, 2015 ª2015 Elsevier Inc. 467
Figure 1. RNase L Deficiency in Mice En-
hances the Lethality of IAVwhile Decreasing
the Induction of IL-1b
(A) Survival of WT and Rnasel/ mice infected i.n.
with IAV.
(B) Mean body weights corresponding to (A).
(C) IL-1b levels determined by ELISAs at 2 days
post-infection (dpi) with IAV in lung homogenates.
(D) IL-1b levels determined by ELISAs at 2 dpi with
IAV in BALF.
(E) TNF-a levels determined by ELISAs at 2 dpi with
IAV in lung homogenates.
(F) TNF-a levels determined by ELISAs at 2 dpi with
IAV in BALF.
(G) Viral titers from lungs harvested at 7 dpi,
determined by plaque assays. Horizontal lines,
mean ± SD.
Significance was determined by Kaplan-Meier
analysis for (A) and (B) or two-tailed Student’s
t tests for (C)–(G). ***p < 0.001; **p < 0.01; *p < 0.05;
ns, not significant. Numbers of mice used: n = 14
(A and B); n = 8 (C and E); n = 11 (D); n = 9 (F); and
n = 8 (G). See also Figure S1.Involvement of MAVS, but Not RIG-I and/or MDA5, in
Viral Activation of the NLRP3 Inflammasome
In BMDC, viral induction of IL-1b, but not TNF-a, was dependent
on both NLRP3 and ASC (Figures 3A and 3B). In addition, MAVS,
but not RIG-I or MDA5 either alone or in combination (double
knockout), was required for optimal induction of IL-1b by VSV
or IAV (Figure 3C). TNF-a levels were unaffected by RIG-I and/
orMDA5 or byMAVS (Figure 3D). In contrast to effects of viruses,
IL-1b induction by ATP was independent of MAVS (Figure S3). In
control experiments, we ruled out differences in cell death rates
as a cause of the reduction in IL-1b production observed in LPS-
treated, virus-infected Mavs/ BMDM (data not shown). These
results show that activation of the NLRP3 inflammasome during
infection with either VSV or IAV is dependent on MAVS for
optimal activation, but not on RIG-I and/or MDA5.
Activation of RNase L Stimulates the NLRP3
Inflammasome
To determine the effect of RNase L activation on the NLRP3
inflammasome, BMDC fromWT and Rnasel/mice were trans-
fected with (20-50)p3A3 (2-5A), a potent and highly specific acti-468 Cell Host & Microbe 17, 466–477, April 8, 2015 ª2015 Elsevier Inc.vator of RNase L (Chakrabarti et al.,
2011). Characteristic RNase L-mediated
rRNA cleavage products (Silverman
et al., 1983) were observed following
(20-50)p3A3 transfection of WT, but not
Rnasel/ BMDC (Figure 4A). Similarly,
IL-1b induction was observed after
(20-50)p3A3 transfection of WT, but not
Rnasel/ BMDC (Figure 4B, top panel).
In addition, immunoblots of cell superna-
tant (Sup) showed (20-50)p3A3 induction
of mature IL-1b (p17) and of cleaved
caspase-1 (p20) in WT, but not in
Rnasel/ BMDC (Figure 4B, bottom
panel). (20-50)p3A3 induction of IL-1b wasdependent on both NLRP3 and ASC (Figure 4C). These results
show that direct activation of RNase L with (20-50)p3A3 causes
IL-1b production in BMDC.
RNA Cleavage Products Activate the NLRP3
Inflammasome
We next investigated effects of RNase L-cleaved RNA on the
NLRP3 inflammasome. Either IAV genomic RNA or cellular
RNA were cleaved in vitro with purified, recombinant human
RNase L activated by (20-50)p3A3. Kinetics of RNA cleavage
were monitored with a FRET probe in parallel reactions contain-
ing cellular or IAV genomic RNA (Figures S4A and S4B). In addi-
tion, cleavage of cellular and IAV genomic RNAwasmonitored in
RNA chips (Agilent) (Figures S4C and S4D, respectively).
Transfection of intact IAV genomic RNA into Pam3Csk4-
primed WT and Rnasel/ BMDC induced mean averages of
249 and 143 pg/ml of IL-1b, respectively (Figure 5A). However,
prior cleavage of IAV RNA by RNase L increased IL-1b induction
to mean averages of 572 and 576 pg/ml in WT and Rnasel/
BMDC, respectively (Figure 5A). The similar levels of IL-1b in
these two cell types were consistent with effects of the cleaved
Figure 2. Inflammasome Activation in Response to Viral Infections Is Reduced in the Absence of RNase L
(A–C) IL-1b levels by ELISAs from (A) WT and Rnasel/ BMDC primed with LPS for 6 hr and infected with VSV for 12 hr or IAV for 24 hr, (B) WT and Rnasel/
BMDC primed with TNF-a for 6 hr and infected with VSV for 12 hr, and (C) BMDC primed with LPS for 6 hr and treated with extracellular ATP (0.5 mM) for 1 hr.
(D and E) IL-1b mRNA levels by qRT-PCR (D) and TNF-a levels by ELISAs (E) from LPS-primed WT and Rnasel/ BMDCs without or with VSV infection.
(F) Cleavage of caspase-1 and proIL-1b in LPS-primed WT and Rnasel/ BMDCs without or with VSV or IAV infection determined in immunoblots. Cell lysates,
Lys; cell supernatants, Sup; error bars, SD; **p < 0.01; ***p < 0.001 by two-tailed Student’s t tests. See also Figure S2.RNAs acting in a pathway downstream of RNase L. Intact cellular
RNA failed to induce IL-1b in either WT or RNasel/ BMDC. In
contrast, cleaved cellular RNA induced mean averages of 360
and 435 pg/ml of IL-1b inWT andRnasel/BMDC, respectively.
There was no effect of IAV genomic or cellular RNA, either intact
or cleaved, on TNF-a levels following Pam3Csk4 treatment (Fig-
ure 5B). Immunoblot analysis showed enhanced inflammasome
activation when cleaved IAV RNA or cleaved cellular RNA were
transfected compared with intact RNAs (Figure 5C). The effect
was more evident in the case of cellular RNA in that there was
no detectable processing of proIL-1b or procaspase-1 p45
when transfecting intact RNA, but there was pronounced pro-
cessing of both proteins in response to cleaved RNA. Nlrp3/
and Asc/ BMDC were defective for IL-1b induction and for
procaspase-1 and proIL-1b processing in response to cleaved
RNA (Figures 5D and 5E). In addition, there was a partial depen-
dence on MAVS (a decrease of 62% inMavs/ BMDC), but not
RIG-I or MDA5, for induction of IL-1b and for NLRP3 activation
(Figures 5F and 5G). Also, there was no effect of a doubleCellknockout of RIG-I and MDA5 on IL-1b induction by RNase
L-cleaved cellular RNA, indicating that these RLRs were non-
redundant in their lack of effect (Figure S4E). TNF-a levels
were unaffected by either cleaved or uncleaved cellular RNA
(Figures S4F and S4G).
To determine which moieties of the cleaved RNAs might
contribute to inflammasome activation, the 20,30-cyclic phos-
phoryl termini were removed with T4 polynucleotide kinase
(PNK) (Figures S4H and S4I) (Nedialkova et al., 2009). The effi-
cacy of PNK in removing 20,30-cyclic phosphates was deter-
mined by cleaving the synthetic RNA substrate, C11U2C7 (Carroll
et al., 1996), with RNase L, followed by incubation of the cleav-
age product, C11U2 >
20,30p, with PNK, or as a control shrimp
alkaline phosphatase (SAP), which requires longer incubation
to remove cyclic 20,30-phosphates (Nedialkova et al., 2009).
Removal of 20,30-cyclic phosphates was monitored by ligation
of the free 30-OH end to [32P]pCp with T4 RNA ligase (Nedialkova
et al., 2009). PNK removed the 20,30-cyclic phosphates within
2 min, whereas SAP required at least 60 min of incubation.Host & Microbe 17, 466–477, April 8, 2015 ª2015 Elsevier Inc. 469
Figure 3. Involvement of NLRP3, ASC, and
MAVS in IL-1b Induction, but Not TNF-a In-
duction, in Response to Viral Infections
(A and B) LPS-primed WT, Nlrp3/, and Asc/
BMDCwere infected with VSV or IAV. (A) IL-1b and
(B) TNF-a levels were measured by ELISAs.
(C and D) LPS-primed WT, Rig I/, Mda5/,
RigI//Mda5/, and Mavs/ BMDC were in-
fected with VSV or IAV. (C) IL-1b and (D) TNF-a
levels were measured by ELISAs. Error bars, SD;
***p < 0.001 by two-tailed Student’s t tests. See
also Figure S3.IL-1b induction in BMDC was decreased from mean averages of
422 to 188 pg/ml when the 20,3-cyclic phosphates were removed
with PNK from RNase L-cleaved cellular RNA (Figure 5H, top
panel). Furthermore, processing of proIL-1b and procaspase-1
was reduced sharply when the dephosphorylated cleaved RNA
was used (Figure 5H, bottom panel). These findings support a
role for the 20,3-cyclic phosphoryl groups in recognition of the
cleaved RNA during signaling to the NLRP3 inflammasome.
The Enzymatic Activity of RNase L Is Required to
Stimulate the NLRP3 Inflammasome
To investigate the involvement of the endoribonuclease activity
of RNase L in NLRP3 inflammasome activation, RNase L was
first stably depleted in human THP-1 macrophages (Tsuchiya
et al., 1980) with lentivirus expressing shRNA against the
30-UTR of RNase LmRNA (sh-Rnasel) followed by drug selection
(Figure 6A). Subsequently, the RNase L knockdown cells were
reconstituted by expressing WT RNase L or mutant R667A
RNase L (which completely inactivates the ribonuclease func-
tion; Dong et al., 2001) from constructs that lack the natural
30-UTR, including the shRNA target site (Figure 6A). Viral infec-
tions were performed on the THP-1 cells expressing control
shRNA (sh-control) or sh-Rnasel. The parental IAV strain (A/PR/
8/H1N1) produced relatively low levels of IL-1b in the sh-control
cells that were further reduced by 65% in the sh-Rnasel cells
(Figure 6B). An IAV/DNS1 mutant virus, lacking NS1 protein
that counteracts OAS-RNase L (Min and Krug, 2006), produced
a more robust induction of IL-1b in the THP-1 cells. Treatment of
THP-1 cells with sh-Rnasel reduced IL-1b induction by IAV/
DNS1 by 58% compared to the sh-control levels (Figure 6B).470 Cell Host & Microbe 17, 466–477, April 8, 2015 ª2015 Elsevier Inc.Similar partial dependency of IL-1b induc-
tion on RNase L in THP-1 cells was ob-
tained with VSV infection. Also, IAV/
DNS1 produced robust production of
IL-1b in WT, but not in Rnasel/ mouse
peritoneal macrophages (Figure S5A).
Reconstitution of the sh-Rnasel THP-1
cells with WT RNase L enhanced IL-1b in-
duction to 308%of the sh-control levels in
response to IAV/DNS1 (Figure 6C, top
panel). In contrast, the R667A mutant of
RNase L, which lacks ribonuclease activ-
ity (Dong et al., 2001), was deficient in
IAV/DNS1 induction of IL-1b. In addition,
IAV/DNS1 induction of procaspase-1cleavage was enhanced by WT RNase L, but not by R667A
mutant RNase L (Figure 6C, bottom panel). In VSV-infected
THP-1 cells, WT RNase L enhanced IL-1b induction by 271%,
whereas the R667A mutant RNase L was partially deficient for
IL-1b induction (Figure 6D, top panel). In these cells, procas-
pase-1 processing was stimulated by WT, but not by R667A
RNase L (Figure 6D, bottom panel). To further validate the
involvement of RNase L in inflammasome activation in THP-1
cells, RNase L levels were depleted with siRNA. Procaspase-1
processing in response to IAV/DNS1 infection was reduced in
cells depleted for RNase L (Figure S5B). IL-1b induction was
decreased in the si-Rnasel-treated cells in response to IAV/
DNS1 infection, but not in response to LPS/ATP (Figure S5C).
These findings demonstrate that the NLRP3 inflammasome is
dependent on the nuclease function of RNase L. In addition,
these results extend the stimulatory effect of RNase L on inflam-
masome activation to human cells.
Involvement of DHX33 in RNase L Signaling to the
NLRP3 Inflammasome
The DExD/H-box RNA helicase, DHX33, was recently shown to
bind dsRNA and to interact with and activate NLRP3 (Mitoma
et al., 2013). To determine whether DHX33 was a sensor for
RNA cleavage products of RNase L, we depleted either DHX33
or, as a control, the helicase DDX1 in THP-1 cells by means of
shRNA expressed from recombinant lentiviruses. DDX1 is a
helicase family member implicated as a dsRNA sensor and
as an inducer of type I IFN (Zhang et al., 2011). Efficient
knockdown of both proteins was obtained as determined in im-
munoblots (Figure 7A). Transfection with the synthetic dsRNA,
Figure 4. IL-1b Production by Direct Activa-
tion of RNase L Is Dependent on Both
NLRP3 and ASC
BMDCwere primedwith Pam3Csk4 (200 ng/ml) for
16 hr and mock transfected or transfected with
(20-50)p3A3 for an additional 8 hr as indicated.
(A) rRNA cleavage in response to (20-50)p3A3
transfection was monitored in RNA chips.
(B and C) IL-1b and cleaved caspase-1 was
measured in cell supernatants (Sup), whereas
proIL-1b, procaspase-1, and b-actin were mea-
sured in cell lysates (Lys). Top panels, ELISAs;
bottom panels, immunoblots. Error bars, SD; ***p <
0.001 by two-tailed Student’s t tests.poly(rI):poly(rC)(pIC), potently induced IL-1b in control shRNA
(sh-control) cells and in DDX1-depleted (sh-Ddx1) cells. In
contrast, IL-1b induction by pIC was reduced by 52% in
the DHX33-depleted (sh-Dhx33) cells (Figure 7B, top panel),
similar to previously reported results by others (Mitoma
et al., 2013). Induction of IL-1b by either VSV or IAV/DNS1
was unaffected by reducing expression of DDX1, whereas
depleting DHX33 reduced IL-1b levels by 61%and 71%, respec-
tively, of the sh-control levels (Figures 7C and 7D, top panels).
Cleavage of procaspase-1 (p45) to p20 was also deficient in
DHX33-depleted, pIC-treated, or virus-infected cells (Figures
7B–7D, bottom panels). Similarly, IL-1b induction following
transfection of either cleaved cellular RNA or (20-50)p3A3 was
reduced by 47% and by 51% of the sh-control levels in
DHX33-depleted cells (Figure 7E, top panel). Procaspase-1
cleavage was also deficient in the DHX33-depleted THP-1 cells
transfected with either cleaved RNA or (20-50)p3A3 (Figure 7E,
bottom panel).
Interaction of DHX33, MAVS, and NLRP3 in Response to
Cleaved RNA
To determine whether RNase L-mediated RNA cleavage prod-
ucts cause DHX33, NLRP3, and MAVS to associate in intact
cells, immunoprecipitations were performed (Figures 7F and
7G). Total cell RNA was left intact, cleaved with RNase L, or
cleaved and dephosphorylated with PNK. THP-1 macrophages
were then transfected with these RNAs or with pIC, and immu-
noprecipitations (IP) were performed on cell extracts followed
by immunoblotting. After transfection with cleaved cell RNA
or with pIC, IP of NLRP3 pulled down both DHX33 and
MAVS, while IP of DHX33 pulled down NLRP3 and MAVS (Fig-
ure 7F). Similar results were obtained with pIC transfections as
previously reported (Mitoma et al., 2013). In contrast, no com-
plexes of DHX33-MAVS-NLRP3 were observed in mock-trans-
fected cells or in cells transfected with intact cell RNA or
cleaved and PNK-treated cell RNA. In addition, IP of myc-
tagged MAVS pulled down flag-tagged NLRP3 and DHX33 in
HEK293T cells in response to cleaved cell RNA, but not with
intact or cleaved and PNK-treated cell RNA (Figure 7G). These
results show that a complex containing DHX33, MAVS, and
NLRP3 is formed in response to RNase L-cleaved RNA that
was dependent on the PNK-sensitive 20,30-cyclic phosphoryl
group.CellRNase L-Cleaved RNA Directly Interacts with DHX33
To determine if cleavage by RNase L directly affects the affinity
of RNA for DHX33, biotinylated RNA was synthesized in vitro
from the IAV M gene cDNA and incubated with purified flag-
tagged DHX33. The biotinylated RNA was then pulled down
with streptavidin beads followed by immunoblotting for DHX33
(as described by Mitoma et al., 2013). Interaction between
RNA and DHX33 was greatly increased following cleavage by
RNase L (Figure 7H). In contrast, PNK treatment resulted in a
loss of affinity for DHX33. The interaction was blocked with un-
modified cleaved RNA, whereas unlabeled intact RNA reduced
but did not completely block binding, and unlabeled RNA that
was cleaved and PNK treated was ineffective (Figure S6). These
findings indicate that RNase L-generated RNA cleavage prod-
ucts have enhanced affinity for DHX33, dependent on the
PNK-sensitive cyclic phosphoryl groups at the 20,30 termini.
DISCUSSION
Our results show that RNase L activation in immune cells
enhances activation of NLRP3 inflammasomes, resulting in
increased secretion of IL-1b. Inflammasome activation during
IAV infections was previously linked to a reduction in tissue dam-
age due to effects on cell recruitment and tissue repair in the lung
(Allen et al., 2009; Iwasaki and Pillai, 2014; Thomas et al., 2009).
In particular, epithelial necrosis and pulmonary functions were
more severely compromised in Nlrp3-deficient mice in response
to IAV infections (Thomas et al., 2009). In addition, a prior study
showed that IL-1b promotes adaptive immunity, thus controlling
IAV infections, and is protective in a mouse model (Pang et al.,
2013). We showed here that during IAV infection levels of IL-1b
were significantly elevated in lung tissue and BALF from WT
compared with Rnasel/ mice. Therefore, it is likely that RNase
L contributes to animal survival from IAV infections at least partly
by enhancing IL-1b production. When RNase L was absent, in-
fections with either VSV or IAV resulted in reduced cleavage of
procaspase-1 and proIL-1b to their mature forms. Similar to
some previous studies, we observed that IL-1b induction by
either VSV or IAV requires both inflammasome proteins,
NLRP3 and ASC (Allen et al., 2009; Ichinohe et al., 2009; Rajan
et al., 2011; Thomas et al., 2009). A role for RLRs is more contro-
versial in that contrasting studies showed either involvement
(Poeck et al., 2010) or no involvement (Rajan et al., 2011) ofHost & Microbe 17, 466–477, April 8, 2015 ª2015 Elsevier Inc. 471
Figure 5. RNase L Generated RNA Cleavage Products Bearing 20,30-Cyclic Phosphates Induce IL-1b Production
(A–C)WT andRnasel/BMDCwere primed with Pam3Csk4 (200 ng/ml) for 16 hr and transfectedwith intact or RNase L-cleaved IAVRNAor cellular RNA for 8 hr.
(A) IL-1b or (B) TNF-a levels were measured by ELISAs. (C) Cleavage of Pro-IL-1b or caspase-1 (p45) was monitored in immunoblots.
(D–H) BMDC of different genotypes (as indicated) were primed with Pam3Csk4 and transfected with uncleaved or RNase L-cleaved cellular RNAs for 8 hr. In WT,
Rnasel/,Nlrp3/, and Asc/BMDC (D) IL-1bwasmeasured by ELISAs and (E) Pro-IL-1b and caspase-1 (p45) cleavage wasmeasured by immunoblotting. In
WT, RigI/, Mda5/, and Mavs/ BMDC (F) IL-1b levels were measured by ELISA and (G) Pro-IL-1b and caspase-1 (p45) cleavage was measured by
immunoblotting. (H) Intact, cleaved, or cleaved and PNK-treated cellular RNA were transfected into Pam3Csk4-treated BMDC. Top: IL-1b levels were measured
by ELISA. Bottom: Pro-IL-1b and caspase-1 (p45) cleavage was measured by immunoblotting.
Cell supernatants, Sup; cell lysates, Lys. Error bars, SD; **p < 0.01; ***p < 0.001 by two-tailed Student’s t tests. See also Figure S4.
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Figure 6. A Functional Nuclease Domain in
RNase L Is Required for Inflammasome
Stimulation
(A) RNase L levels in THP-1 cells or expressing sh-
Rnasel alone or with Flag-tagged WT or R667A
mutant RNase L cDNAs. Immunoblots were pro-
bed with monoclonal antibody to human RNase L
(top), antibody to Flag epitope (middle), and anti-
body to b-actin (bottom).
(B) IL-1b and caspase-1 (p20) in cell supernatants
(Sup) and procaspase-1 (p45) and b-actin in cell
lysates (Lys) from THP-1 cells expressing sh-con-
trol or sh-Rnasel and infected with IAV, IAV/DNS1,
or VSV.
(C and D) THP-1 cells expressing Rnasel shRNA or
reconstituted with WT or mutant R667A RNase L
infected with IAV/DNS1 (C) or VSV (D).
For (B)–(D): top panels, ELISAs; bottom panels,
immunoblots. Error bars, SD; ***p < 0.001 by two-
tailed Student’s t tests. See also Figure S5.RIG-I in caspase-1-dependent inflammasome activation in
response to VSV. Our data agree with the latter study in
that IL-1b secretion during VSV infections was completely inde-
pendent of RIG-I. Indeed, single or combined deficiencies in
RIG-I and/or MDA5 failed to impair IL-1b secretion in response
to either VSV or IAV, indicating that these RNA helicases
are non-redundant in their lack of effect. In contrast to RLRs,
the adaptor MAVS was required for optimal activation of
induction of IL-1b in response to either IAV or VSV infections,
as well as for IL-1b secretion upon transfection with RNase
L-generated RNA cleavage products. MAVS was previously
implicated in NLRP3 inflammasome activation in response to
different stimuli (Subramanian et al., 2013), including Sendai
virus (Park et al., 2013). MAVS promotes localization of the
NLRP3 inflammasome to the mitochondria (Park et al., 2013;
Subramanian et al., 2013). However, there was no effect of
NLRP3, ASC, or MAVS on viral induction of TNF-a, a cytokine
that is not processed by inflammasomes. In addition, whereas
a previous study show MAVS dependence for NLRP3 activation
by ATP (Subramanian et al., 2013), we found no effect of MAVS
deletion on NLRP3 activation by ATP (Figure S3) (Franchi et al.,
2014).Cell Host & Microbe 17, 466Prior studies investigated how priming
(signal 1) and activation (signal 2) of the
NLRP3 inflammasome occurs during IAV
infections (reviewed in Iwasaki and Pillai,
2014). Signal 1 (priming) was not ob-
served in response to VSV or IAV as deter-
mined by a lack of IL-1b secretion unless
an NF-kB stimulus such as TNF-a or LPS
was used. However, after priming, both
VSV and IAV resulted in a robust signal 2
in WT, but not in Rnasel/ BMDC. Direct
and highly specific activation of RNase L
by the 2-5A triadenylate, (20-50)p3A3, trig-
gered NLRP3 inflammasome activation
as measured by processing of proIL-1b
and procaspase-1 and by IL-1b secretion.
However, RNase L activation by 2-5A didnot induce IL-1b in BMDC lacking either NLRP3 or ASC. Evi-
dence points to a role for the RNase L-generated RNA cleavage
products in inflammatory signaling. Whereas intact IAV genomic
RNA, but not intact cellular RNA, modestly stimulated NLRP3,
RNA cleavage products from RNase L-mediated digestion of
either type of RNA highly stimulated the NLRP3 inflammasome.
Activation by the RNA cleavage products was dependent on
NLRP3 and ASC, with a requirement for MAVS for optimal activ-
ity, whereas RIG-I and/or MDA5 had no effect. During IAV infec-
tions in vivo, commensal bacteria are believed to provide the
priming step (signal 1) (Ichinohe et al., 2011), whereas signal 2
is provided by viral ssRNA (Thomas et al., 2009), proton flux
through the viral-encoded matrix 2 (M2) trans-Golgi ion channel
(Ichinohe et al., 2010), and amyloid-like structures of the IAV
virulence protein, PB1-F2 (McAuley et al., 2013). Our results sug-
gest that RNA cleavage products from RNase L activity during
IAV infections are additional stimuli for NLRP3 inflammasome
activation.
RNase L is often activated in virus-infected cells, where it
cleaves single-stranded regions of host and viral RNAs, predom-
inantlyafterUUorUAdinucleotides leavingas termini 50-hydroxyls
and 20,30-cyclic phosphates (Cooper et al., 2014;Wreschner et al.,–477, April 8, 2015 ª2015 Elsevier Inc. 473
Figure 7. Involvement of DHX33 in RNase L-Mediated Inflammasome Activation
(A) shRNA mediated depletion of DDX1 or DHX33 in THP-1 macrophages.
(B–E) THP-1 macrophages expressing different shRNAs (sh-control, sh-Ddx1, or sh-Dhx33) were (B) transfected with pIC (2 mg/ml for 8 hr), (C) infected with VSV,
(D) infected with IAV/DNS1, and (E) mock transfected or transfected with cell RNA cleaved with RNase L or transfected with (20-50)p3A3. Top panels, ELISAs;
bottom panels, immunoblots (IB).
(F) THP-1 macrophages were transfected with intact, cleaved, cleaved and PNK-treated cellular RNA or pIC. Immunoprecipitations (IP) were with anti-NLRP3,
anti-DHX33, or an isotype control IgG. Cell lysates were used as controls (bottom panel).
(G) HEK293T cells were co-transfected with myc-MAVS and flag-NLRP3 cDNAs. After 72 hr, cells were transfected with intact, cleaved, or cleaved and PNK-
treated cellular RNA. IPs were with anti-myc followed by immunoblotting (IB) with anti-flag, anti-DHX33, or anti-myc antibodies. Cell lysates were used as controls
(bottom panel).
(H) Purified flag-DHX33 was incubated with biotinylated IAV M gene RNA (intact, cleaved, or cleaved and PNK treated). Biotinylated RNAs were precipitated with
streptavidin beads followed by IB with anti-flag antibody to detect DHX33. Cell supernatants, Sup; cell lysates, lys. Error bars, SD; **p < 0.01; ***p < 0.001 by two-
tailed Student’s t tests. See also Figure S6.1981). We showed here that optimal activation of the NLRP3 in-
flammasome by these RNA cleavage products depends on the
20,30-cyclic phosphate termini. IRE1, a kinase-endoribonuclease
that functions in the unfolded protein response, also produces
20,30-cyclic phosphorylated termini, which are immunostimulatory
(Eckard et al., 2014). It remains to be determined whether other
features of the RNA cleavage products from RNase L activity474 Cell Host & Microbe 17, 466–477, April 8, 2015 ª2015 Elsevier Incontribute to the effect, in particular double-stranded regions
that are left intact by this enzyme.
Previously, the NLRP3 inflammasome was shown to be acti-
vated in macrophages by transfection of either viral RNA or the
synthetic dsRNA, pIC (Kanneganti et al., 2006a). Themechanism
whereby NLRP3 senses viral dsRNA is unknown, but it is
believed to be indirect, as has been suggested for sensingc.
microbial PAMPs by NLR-like proteins in plants (Mackey et al.,
2003). DHX33 is a DExD/H-box RNA helicase with a helicase C
type domain, similar to RIG-I and MDA5, but lacking a CARD
domain (Liu et al., 2014). DHX33 interacts with dsRNA, MAVS,
and NLRP3, and its depletion rendered human macrophages
resistant to caspase-1 activation and secretion of IL-1b and IL-
18 (Liu et al., 2014;Mitoma et al., 2013). DHX33 is also implicated
in dsRNA signaling to the type I IFN genes in response to either
pIC or reovirus (Liu et al., 2014). Our data indicate involvement of
RNase L-mediated RNA cleavage products generated in virus-
infected cells in NLRP3 activation through DHX33 and MAVS.
Cleaved RNA products generated by RNase L caused formation
of a complex containing DHX33, MAVS, and NLRP3. Current
findings are consistent with a previous study showing that pIC
stimulated a complex containing DHX33, NLRP3, and ASC
(Mitoma et al., 2013). Moreover, the RNA cleavage products
directly bind to DHX33. Both immune complex formation and
affinity for DHX33 were ablated by PNK treatment of the cleaved
RNA, which removes 20,30-cyclic phosphate from the RNA. Our
results suggest a model in which direct binding of the cleaved
RNA to DHX33 stimulates association with MAVS and NLRP3,
inducing oligomerization and recruitment of procaspase-1
through ASC. Recently, it was shown that dsRNA acts through
NLRP3 and MAVS to induce membrane damage and potassium
efflux to activate NLRP3 (Franchi et al., 2014). Perhaps the
DHX33-MAVS-NLRP3 complex induced by cleaved RNA is
also activated by potassium efflux. However, whereas RIG-I
and MDA5 are redundant for pIC stimulation of the NLRP3 in-
flammasome (Franchi et al., 2014), that was not the case for
RNA cleavage products generated by RNase L, suggesting
that at some level, immune signaling by these different RNA spe-
cies is distinct (Figure S4E).
RNase L is a relatively general antiviral enzyme capable of in-
hibiting a broad range of RNA and DNA viruses (Silverman,
2007). Future studies will determine the range of viruses that
stimulate inflammasomes through RNase L. Also, structural or
sequence requirements in the RNA cleavage products may be
further defined. Additional co-factors that contribute to the im-
mune signaling pathway may be explored, such as possible
involvement of other DExD/H-box helicases. It will also be inter-
esting to know whether OAS and RNase L affect other types of
NLR- or non-NLR-inflammasomes. Taken together, our findings
suggest that during viral infections RNase L-generated RNA
cleavage products are sensed by DHX33, leading to NLRP3
activation.
EXPERIMENTAL PROCEDURES
Cell Culture
Bone marrow cells isolated from hind limbs of 8- to 12-week-old C57BL6
WT, Rnasel/ (Zhou et al., 1993), Nlrp3/ (Kanneganti et al., 2006b), Asc/
(Ozo¨ren et al., 2006), RigI/ (Kato et al., 2005), Mda5/ (Gitlin et al., 2006),
RigI/Mda5/ (Errett et al., 2013), and Mavs/ mice (see Supplemental
Information) were grown and differentiated in Iscove’s modified Dulbecco’s
medium (IMDM) containing 10% (v/v) heat-inactivated fetal bovine serum
(FBS), 1% non-essential amino acids, 50 mM b-mercaptoethanol, and
20 ng/ml of GM-CSF for 9 days before they were used for experiments.
THP-1 cells (ATCC TIB-202) were maintained in RPMI-1640 medium contain-
ing 10% (v/v) heat-inactivated FBS, 1% non-essential amino acids, and 50 mM
b-mercaptoethanol. HEK293T cells and MDCK cells were maintained in
DMEM with 10% (v/v) heat-inactivated FBS.CellViruses
IAV A/PR/8/34 (H1N1) grown in 11-day embryonated chicken eggs and
IAV/DNS1 lacking the NS1 gene were kindly provided by Adolfo Garcia-
Sastre (New York) (Gack et al., 2009). IAV/DNS1 was grown in MDCK-NS1
cells (Gack et al., 2009) with DMEM supplemented with 0.3% bovine albumin,
1% penicillin streptomycin, and 1 mg/ml of L-(tosylamido-2-phenyl) ethyl
chloromethyl ketone (TPCK)-treated trypsin (Sigma-Aldrich). Vesicular stoma-
titis virus (VSV, Indiana strain; a gift fromDr. Amiya Banerjee) was grown in CV1
cells.
Viral Infections of Mice
Male mice (6 weeks of age) anesthetized with ketamine-xylazine were
infected intranasally (i.n.) with 1 3 105 pfu of IAV (in 20 ml). BALF was
collected by washing the trachea and lungs twice and injecting a total
of 2 ml PBS containing 0.1% BSA (Ichinohe et al., 2009). BALF was
used for cytokine measurements. Lungs of infected mice were excised
at 7 dpi and homogenized in 1 ml PBS using a mechanical homogenizer.
The viral titers were quantified by plaque assay on MDCK cells as
described previously (Manicassamy et al., 2010). Experiments involving
mice were performed under an approved IACUC protocol from the Cleveland
Clinic.
Viral Infection of Cells
BMDCwere primed with LPS (100 ng/ml) or TNF-a (25 ng/ml) for 6 hr, washed,
and infected with VSV (moi = 1) and IAV (moi = 1) for 12 and 24 hr, respec-
tively, in serum-free IMDM. THP-1 cells were treated with PMA (80 ng/ml)
for 16 hr, washed, and cultured in complete (with 10% FBS) RPMI media
for an additional 48 hr. Differentiated THP-1 cells were placed in serum-free
RPMI followed by infection with VSV, IAV, or IAVDNS1 (each at moi = 1) for
90 min. Subsequently, the THP-1 cells were replenished with complete
RPMI media for an additional 12 and 24 hr, respectively. Supernatants were
collected for ELISAs, and both supernatants and lysates were used for
immunoblotting.
Transfections of BMDC
BMDCs were primed with Pam3Csk4 (200 ng/ml) for 16 hr. The cells were sub-
sequently transfected with viral RNA (100 ng/ml), cellular RNA (250 ng/ml), or
(20-50)p3A3 (10 mM) with Lipofectamine 2000 (Life Technologies) for an addi-
tional 8 hr.
ELISAs
ELISAs for mouse IL-1b and TNF-a and for human IL-1b were performed as
described (BD Biosciences).
IL-1b mRNA Levels
Mouse IL-1b mRNA expression was determined by qRT-PCR using the
following primer pair with SYBR green. Forward: 50-GCAACTGTTCCTGAACT
CAACT-30; reverse: 50-ATCTTTTGGGGTCCGTCAACT-30 (Primer Bank ID:
6680415a1; http://pga.mgh.harvard.edu/primerbank/index.html).
Co-immunoprecipitation Assays
THP-1 cells (1 3 107) were differentiated with PMA (80 nM) and then trans-
fected with 300 ng of cellular RNAs (intact or RNase L cleaved or cleaved
and PNK treated) or pIC with Lipofectamine 2000. After 4 hr, the cells were re-
suspended in lysis buffer (50 mM Tris [pH 7.5], 150 mM NaCl, 0.1% [v/v]
Nonidet-P40, 5 mM EDTA, and 10% [v/v] glycerol). Lysates were immunopre-
cipitated with control rabbit immunoglobulin G (IgG) or anti-DHX33 antibody or
anti-NLRP3 antibody (Cell Signaling Technology, D2P5E) with protein A
agarose (Sigma-Aldrich). Myc-tagged MAVS cDNA (0.5 mg) and Flag-tagged
NLRP3 cDNA (0.5 mg) were co-transfected into HEK293T cells with Lipofect-
amine 2000. After 72 hr, the cells were transfected with 300 ng of cellular
RNAs (intact, cleaved, or cleaved and PNK treated). At 4 hr after transfection,
cells were lysed in buffer (50 mMTris [pH 7.5], 300mMNaCl, 1% [v/v] Triton-X,
5 mM EDTA, and 10% [v/v] glycerol). Lysates were immunoprecipitated with
anti-myc antibody (Sigma-Aldrich) with protein G agarose (GE Healthcare
Life Sciences).
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